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Introduction. Recent reports have described the occurrence of low-energy subtrochanteric and femoral sha fractures associated
with long-term bisphosphonate use. Although information regarding the surgical treatment of these atypical femoral fractures is
increasing, it is unclear if the preventive operation is useful in incomplete fractures. is study examined the results of preventive
intramedullary nailing for incomplete atypical femoral fractures.Material and Methods. A retrospective search was conducted for
patients older than 50 years receiving bisphosphonate therapy, with incomplete, nondisplaced fractures in either the subtrochanteric
or diaphyseal area of the femur. Seventeen patients with a total of 20 incomplete, non-displaced lesions were included. e mean
duration of bisphosphonate use was 50.5 months. Eleven of the 17 (64.7%) patients had complete or incomplete fractures on
the contralateral femur. All were treated with prophylactic �xation of an intramedullary (IM) nail. e minimum followup was
12 months. Results. All cases healed with a mean period of 14.3 weeks. Nineteen of the 20 cases healed with the dissolution of
incomplete fractures of the lateral aspect. A complete fracture developed at the time of nailing in one patient, but it healedwith callus
bridging. Conclusion. IM nailing appears to be a reliable way of preventing the progress of incomplete atypical femoral fractures.
1. Introduction
Bisphosphonate (BP)medication has been themainstay treat-
ment of postmenopausal osteoporosis andmetastatic diseases
to the skeleton [1–4]. Although its eﬃcacy is well known,
several reports have described the bisphosphonate-associated
insuﬃciency fractures of the femur amongpatients associated
with long-term BP use [5]. Some studies have suggested
that chronic suppression of bone turnover may produce
hypermineralized bone, which ismore brittle.ese fractures
diﬀer from the typical proximal femoral fracture associated
with osteoporosis. ey are caused by low-energy mecha-
nisms, with the typical radiographic features of unicortical
beaking and hypertrophy of the diaphyseal cortex, appearing
as insuﬃciency fractures [6, 7]. e prefracture radiographs
of atypical femoral fractures have been described and include
cortical thickening or beaking as well as a transverse line in
the femoral cortex [8]. Several studies have reported that MR
may �nd an incomplete lesion of atypical femoral fractures.
ese lesions have the potential to progress to complete
fractures with associated thigh pain.
e decision to treat incomplete atypical femoral frac-
tures nonsurgically or surgically is controversial. Although
activity modi�cation with partial weight bearing on the
aﬀected extremity is an option, it does not appear to be a
reliable way of treating these fractures because the majority
progress to fracture completion [9, 10]. Prophylactic �xation
may prevent the fracture from progressing and the related
morbidity. On the other hand, few studies have reported
the results and risks of prophylactic �xation [11]. is study
describes the ultimate outcomes of patients with incomplete
atypical femoral fractures treated with intramedullary nail-
ing.
2. Patients andMethods
A search of the fracture databases from three trauma centers
was performed to identify patients older than 50 years
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with incomplete, non-displaced stress fractures in either the
subtrochanteric or diaphyseal area of the femur between
January 2008 and August 2010. Of these, 17 patients (20
fractures) with fractures radiographically characteristic of a
bisphosphonate-associated incomplete stress femoral frac-
ture were included in this study. e study design and
protocol were approved by the Institutional Review Board.
e inclusion criteria were as follows: (1) incomplete atypical
femur fracture, as de�ned on the radiographs, (2) prophy-
lactic IM nailing for incomplete fractures, and (3) clinical
followup for at least one year aer the index operation.
Eleven of the 17 (64.7%) patients (14 fractures) had
complete or incomplete fractures of the contralateral femur.
e other 6 patients did not show these lesions up to the latest
followup. All except for three had a documented history of
bisphosphonate use at the time of presentation. All patients
were female with a mean age of 68.3 years (range, 54∼83).
e bone mineral density was evaluated in all cases by dual-
energy X-ray absorptiometry (DEXA), which showed amean
𝑇𝑇-score of −2.97 (range, −1.7∼ −5.2). Eleven of the 14
patients (78.6%) had been treated with alendronate, two
patients were treated with risedronate, and one patient was
treated with ibandronate. e average length of treatment
with bisphosphonates was 50.5 months (range, 6∼102). All
patients had a minimum followup of 12 months (mean, 20.1;
range, 12∼33). All patients were recalled speci�cally for this
study to assess the current physical status. e data was also
obtained from medical records and radiographs.
Six fractures were located in the subtrochanteric area
and 14 were located in the femoral sha. All except one
fracture lines located within lateral cortex only, whereas one
fracture at subtrochanteric region involved more than 2/3
cortical width without displacement (Figure 1). All patients
were treated with prophylactic �xation of an intramedullary
nail. Eleven patients with incomplete contralateral femoral
fractures were also nailed simultaneously or aer primary
operation. Closed IMnailingwith staticmodewas performed
in all cases. e entries of the nail were piriformis fossa in 3
patients and the tip of the greater trochanter in 17 cases. In
the types of IM nail, a standard interlocking nail was used in
9 cases, and a cephalomedullary or reconstruction type nail
was used in 11 cases.
All patients began hip and knee motion exercises, and
weight bearing as tolerated was allowed immediately aer
surgery. Routine follow-up radiographs were obtained every
6∼8 weeks until the fracture line vanished. Radiographic
healing was documented as a loss of fracture lucency on
the standard anteroposterior and lateral femoral radiographs
taken at the standard follow-up intervals, whereas clinical
healing was documented as an absence of pain (in those who
presented without fracture lucency) and/or a loss of fracture
lucency on the radiographs.
3. Results
All cases healed with a mean period of 14.3 weeks (Figure 1).
None of the patients showed any limited motion of the hip
and knee joints, and they could perform their normal daily
(a) (b) (c)
F 1: (a) A 72-year-old woman had pain in her right thigh with
a transverse fracture line and thickening of the lateral cortex in the
subtrochanteric area. (b) She underwent internal �xation using a
proximal femoral nail. (c) At 13 weeks postoperatively, she had no
pain with a dissolution of the fracture line at the lateral cortex.
activities. All could walk without crutches aer a mean of 6
months (4∼8 months).
Nineteen of the 20 cases healed with the dissolution of
the incomplete fracture of the lateral aspect. A complete
fracture developed at the time of nailing in one patient, but
it healed with callus bridging by 18 weeks aer surgery.
is complication was attributed to a mismatch of curvature
between the femoral bow and IM nail (Figure 2).
With the exception of 3 patients with a complete atypical
femoral fracture on the contralateral side, which were oper-
ated simultaneously, the average hospital stay was 5.8 days.
No patients had hardware removed for symptomatic rea-
sons aer the completion of fracture healing. No infections
were documented in any of the study patients.
4. Discussion
Over the past few years, a number of case series have sug-
gested an association between low-energy atypical fractures
of the femur and BP use for osteoporosis management, even
though some of non-BP users also developed similar lesions
[12].e de�nition, incidence, and characteristics of atypical
femoral fractures are unclear, because of multiple associated
risk factors [13]. But, a recent nation-wide study showed
a high prevalence of current bisphosphonate use among
patients with atypical fractures and its relative risk about 47 in
the cohort analysis [14]. erefore, for patients receiving BP
therapy and who reported the symptoms of pain originating
from the femur, an appropriate radiographic examination
of both femurs is recommended to �nd any suspicious
lesions, including the prefracture radiographic �ndings. Sev-
eral studies [9, 10] reported that the spontaneous healing
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(a) (b) (c) (d)
F 2: (a) A 74-year-old woman suﬀered thigh pain and her AP
radiograph showed exaggerated femoral bowing with a transverse
radiolucent line (arrow) in the lateral cortex of the distal 1/3 of the
le femur. (b) A magni�ed view (box arrow) of the lesion revealed
an incomplete, prefracture lesion of an atypical femoral fracture. (c)
Aer preventive IM nailing, a complete fracture occurred. (d) e
unionwas achieved with callus bridging at 18 weeks postoperatively.
of atypical femur fractures was not expected. Most non-
displaced fractures progressed to fractures with secondary
displacement, and complete fractures inevitably developed
even with a low-energy injury. Although established atypical
femoral fractures require surgical treatment, there are few
reports of surgical treatment to prevent incomplete lesions
from progressing to complete fractures. In this study, 20 cases
of incomplete or non-displaced lesions were found. e aim
of this study was to determine the eﬃcacy and results of
preventive IM nailing in patients with incomplete lesions of
atypical femoral fractures.
e union rate varies aer the surgical treatment of
complete atypical femoral fractures. Although Capeci and
Tejwani [6] reported that all 7 fractures achieved union
aer reamed IM nailing, they included four cases of non-
displaced lesions. On the other hand, in a recent study
excluding the prefracture lesions [15], the healing of atypical
femoral fractures aer IM nailing was unsatisfactory with a
low union rate (54%), and many patients required additional
procedures.e result of 100%unionmeans that prophylactic
IM nailing is a meaningful method. is is in contrast to the
long duration of healing and the late return to normal daily
activities aer non-surgical treatment, which is successful
only in a small proportion of cases.
Traditionally, IM nailing of femoral sha fractures was
reported to be a very successful surgical procedure, with a
98% to 99% healing rate and a very low complication rate
[16]. On the other hand, Weil et al. [15] reported a higher
failure rate of IM nailing in atypical femoral fractures.
ey insisted that these fractures might re�ect an impaired
bone healing process rather than the diﬀerences in surgical
technique. In this series, there was only one minor complica-
tion of further fracture during nail insertion, which healed
without secondary procedures. is is comparable to the
report of a high complication rate in a series of complete
fractures [17]. IM nailing is easier before than aer fracture
completion, and the healing time is much less. In addition,
there is a shorter postoperative hospital stay. erefore, the
signi�cance of preventive nailing is noteworthy.
e most frequent complication of IM nailing of atypical
femoral fractures was intraoperative femoral sha comminu-
tion during nail insertion up to 29.4% [17].is complication
was also experienced in non-displaced femoral sha fractures
in the present study, which appears to be an iatrogenic
fracture during nail placement. Lim et al. [18] reported
that femoral bowing deformities are a high-risk factor of
femoral insuﬃciency fractures. e mismatch of curvature
between the implant and femur is believed to be the reason
for this intraoperative complication due to the observation of
exaggerated femoral bowing in the present case.
is study had several limitations. is study was a ret-
rospective case series, and the sample size of this study
was relatively small. Because of the diﬀerent locations of
pathologic lesions, the nails used were not the same. In
addition, plate �xation was not included as a preventive
operation, even though IM nails can be impractical in certain
situations. In a recent report [15], the results of plate �xation
were unsatisfactory in atypical femoral fractures and they
were excluded from the study design.erefore, a prospective
randomized trial with a larger cohort will be needed to
compare IM nailing with plate �xation.
5. Conclusion
Prophylactic �xation of atypical femoral fractures is recom-
mended. Despite the small number of patients who under-
went prophylactic �xation, this procedure appears to achieve
a more eﬃcient postoperative course.
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